Stock listing

LSE:0OCQ Transgene SA Share Price

UK listing (LSE) of Transgene SA · home listing Euronext:TNG

Follow Transgene SA into a list and get an email when it puts out news.

Share price · LSE:0OCQ

€0.716 EUR -0.004 (-0.6%)

Close on Nov 16, 2026

Past year -43.8% · daily closes, Nov 17, 2025 – Nov 6, 2026, adjusted for splits
Day range
€0.716 – €0.722 EURNov 16, 2026
Volume
99 sharesNov 16, 2026
Market cap
€49.22M EURAt the close on Nov 16, 2026 · price × 68.75M shares outstanding
52-week range
€0.677 – €1.350 EURLowest and highest trades, Nov 17, 2025 – Nov 16, 2026
Traded on an average day
€1,824 EURMedian day 407 shares · last 3 months, Aug 17, 2026 – Nov 6, 2026
Transgene SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:TNG · Home€0.715 EUR-0.006 (-0.8%)45,941€0.720€0.720€0.707€0.721Close on Nov 16, 2026
LSE:0OCQ€0.716 EUR-0.004 (-0.6%)99€0.722€0.722€0.716€0.720Close on Nov 16, 2026
OTC:TRGNF$0.745 USD0.000 (0.0%)—$0.745$0.745$0.745$0.745Close on Nov 6, 2026
Frankfurt:TGNA€0.694 EUR-0.012 (-1.7%)—€0.694€0.694€0.694€0.706Close on Nov 16, 2026

Daily closes

Last 3 months, Aug 17, 2026 – Nov 6, 2026 · LSE:0OCQ · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€0.733-0.035-4.6%€0.749€0.749€0.717252
€0.768-0.009-1.2%€0.776€0.776€0.768959
€0.777-0.022-2.8%€0.778€0.778€0.777215
€0.799+0.050+6.7%€0.747€0.812€0.74713,417
€0.749+0.025+3.5%€0.765€0.765€0.74527
€0.724+0.012+1.7%€0.725€0.725€0.7244,791
€0.712-0.033-4.4%€0.724€0.724€0.7071,456
€0.745+0.064+9.4%€0.689€0.745€0.6886,519
€0.681-0.003-0.4%€0.681€0.681€0.6817
€0.684+0.005+0.7%€0.681€0.684€0.67855
€0.679+0.001+0.1%€0.681€0.681€0.6791,670
€0.678-0.001-0.1%€0.678€0.678€0.67816
€0.679+0.002+0.3%€0.683€0.683€0.677308
€0.677-0.007-1.0%€0.683€0.683€0.677144
€0.684-0.001-0.1%€0.689€0.689€0.684213
€0.685-0.008-1.2%€0.694€0.695€0.685106
€0.693-0.001-0.1%€0.693€0.693€0.69325
€0.694-0.007-1.0%€0.694€0.694€0.694391
€0.701-0.001-0.1%€0.701€0.701€0.7017
€0.702+0.005+0.7%€0.698€0.702€0.698210
€0.697-0.014-2.0%€0.709€0.709€0.697292
€0.711-0.020-2.7%€0.729€0.733€0.711290
€0.731-0.004-0.5%€0.723€0.731€0.723436
€0.735+0.035+5.0%€0.705€0.741€0.705320
€0.700-0.020-2.8%€0.707€0.707€0.6941,445
€0.720-0.010-1.4%€0.725€0.725€0.72071
€0.730+0.004+0.6%€0.732€0.732€0.7301,479
€0.726-0.023-3.1%€0.728€0.730€0.726186
€0.749-0.049-6.1%€0.758€0.760€0.749858
€0.798-0.014-1.7%€0.801€0.801€0.798423
€0.812-0.044-5.1%€0.845€0.845€0.8122,343
€0.856+0.001+0.1%€0.855€0.856€0.854927
€0.855-0.002-0.2%€0.854€0.855€0.8501,421
€0.857-0.006-0.7%€0.858€0.860€0.8561,208
€0.863+0.001+0.1%€0.862€0.863€0.862183
€0.862+0.002+0.2%€0.864€0.864€0.8623,368
€0.860-0.015-1.7%€0.860€0.860€0.86067
€0.875-0.004-0.5%€0.875€0.875€0.87538
€0.879-0.002-0.2%€0.879€0.879€0.879269
€0.881-0.004-0.5%€0.880€0.881€0.880987
€0.885-0.005-0.6%€0.887€0.887€0.8761,096
€0.890-0.010-1.1%€0.907€0.969€0.8605,744
€0.900+0.064+7.7%€0.888€0.926€0.8888,402
€0.836-0.051-5.7%€0.886€0.886€0.8364,201
€0.887+0.097+12.3%€0.931€0.958€0.88022,025
€0.790+0.002+0.3%€0.790€0.790€0.7902
€0.788-0.012-1.5%€0.798€0.798€0.788301
€0.800-0.006-0.7%€0.800€0.800€0.80025
€0.806-0.002-0.2%€0.802€0.806€0.802346
€0.8080.0000.0%€0.808€0.808€0.80819
€0.8080.0000.0%€0.810€0.810€0.8066,024
€0.808-0.002-0.2%€0.806€0.808€0.806565
€0.810-0.005-0.6%€0.810€0.810€0.8071,743
€0.815-0.022-2.6%€0.848€0.848€0.8033,571
€0.837+0.015+1.8%€0.860€0.860€0.8309,150
€0.822+0.094+12.9%€0.729€0.880€0.72913,311
€0.728+0.004+0.6%€0.727€0.728€0.72710
€0.724+0.014+2.0%€0.725€0.725€0.7244,864
Ticker
LSE:0OCQ
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
LSE
Currency
EUR

What changed lately

Calls

Replays

  • Transgene (Euronext:TNG) Q4 2025 Earnings Call

    Tue, Mar 24, 2026 · 1:00 PM ET

    Watch Transcript
  • Transgene (Euronext:TNG) Q2 2025 Earnings Call

    Tue, Sep 16, 2025 · 12:00 PM ET

    Watch Transcript

Latest news

All Transgene SA news

Financings

  • Private placement of new ordinary shares

    Nov 25, 2025 · US$121.48M

    Update: about €105M · Van Lanschot Kempen NV +1

    Dealers: Van Lanschot Kempen NV (lead), Swiss Life Banque Privée (co-lead)

    Buyers: TSGH (irrevocably committed to subscribe for at least €70 million); Dassault Group (SITAM Belgium) (with another existing shareholder, intends to participate for €10 million)

    Use of proceeds: Accelerate the myvac individualized cancer vaccine program, R&D costs, and general and administrative expenses; cash runway to early 2028

    Announced Nov 25, 2025 · Update Nov 25, 2025

Read by 6ix AI from the company's releases

Decks

Transgene SA on 6ix

Sector
Health care
Industry
Biotechnology
News releases
36 in the last 12 months · 49 in all · newest Nov 9, 2026 · oldest 2025
Calls
2 calls with a replay · 2 with a transcript · latest Mar 24, 2026
Decks
66 decks · latest Sep 24, 2026

Where Transgene SA is listed

ListingExchangeCountryCurrency
Euronext:TNG · Home listingEuronextFranceEUR
gettex:TGNAgettexGermanyEUR
LSE:0OCQ · This pageLSEUnited KingdomEUR
LS Exchange:913048LS ExchangeGermanyEUR
Lang & Schwarz:913048Lang & SchwarzGermanyEUR
Munich:TGNAMunichGermanyEUR
OTC:TRGNFOTCUnited StatesUSD
Frankfurt:TGNAFrankfurtGermanyEUR
Stuttgart:TGNAStuttgartGermanyEUR
Aquis:TNGPAquisUnited KingdomEUR
Aquis:TNGPAquisUnited KingdomEUR
Dusseldorf:TGNADusseldorfGermanyEUR
Hamburg:TGNAHamburgGermanyEUR
Turquoise:TNGPTurquoiseUnited KingdomEUR

Log in to ask 6ix AI your own questions about Transgene SA.